Firms
Trails Edge Capital Partners
Atlanta, Georgia, United States
Atlanta-based biopharmaceutical investment manager focused on emerging biotechnology companies. It manages the Trails Edge Biotechnology Master Fund and participates in negotiated public company financings, including ProMIS Neurosciences' antibody programs for neurodegenerative diseases and Immunic's multiple sclerosis drug development. Its publicly documented investments also include CAMP4 Therapeutics and ImageneBio.
- Founded
- 2025
- Type
- Venture capital
Funds1
Team
Operations and support
Co-investing
Janus Henderson Investors
CAMP4 Therapeutics$50M · 2026-08-04
Immunic$200M · 2026-02-17
ProMIS Neurosciences$75M · 2026-01-30- CAMP4 Therapeutics$30M · 2025-12-18
- CAMP4 Therapeutics$50M · 2025-09-10
Vivo Capital
- CAMP4 Therapeutics$50M · 2026-08-04
- Immunic$200M · 2026-02-17
- CAMP4 Therapeutics$30M · 2025-12-18
- CAMP4 Therapeutics$50M · 2025-09-10
5am Ventures
- CAMP4 Therapeutics$50M · 2026-08-04
- CAMP4 Therapeutics$50M · 2025-09-10
EcoR1 Capital- Immunic$200M · 2026-02-17
- CAMP4 Therapeutics$30M · 2025-12-18
Woodline Partners- Immunic$200M · 2026-02-17
- ProMIS Neurosciences$75M · 2026-01-30
Ally Bridge Group
- ProMIS Neurosciences$75M · 2026-01-30
Avidity Partners
- Immunic$200M · 2026-02-17
BVF Partners L.P.
- Immunic$200M · 2026-02-17
Deep Track Capital
- ProMIS Neurosciences$75M · 2026-01-30
Great Point Partners- ProMIS Neurosciences$75M · 2026-01-30
Neil K. Warma- ProMIS Neurosciences$75M · 2026-01-30
RA Capital Management
- Immunic$200M · 2026-02-17
Wellington Management
- ProMIS Neurosciences$75M · 2026-01-30